InvestSMART

TrivarX Ltd (ASX: TRI) - Announcements

Current share price for TRI : $0.020 0.001 (2.50%)+

ASX company news and announcements for TrivarX Ltd (TRI) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All TrivarX Ltd (TRI) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than TrivarX Ltd (TRI), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for TrivarX Ltd (TRI)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$22 Extension of Trading Suspension 13 Oct 2025 8:55AM $0.011 $0.020 risen by 77.27%
$22 Suspension from Quotation 9 Oct 2025 9:11AM $0.011 $0.020 risen by 77.27%
$22 Inadvertent Lift of Trading Halt 8 Oct 2025 11:01AM $0.012 $0.020 risen by 62.50%
$22 Pause in trade 8 Oct 2025 10:28AM $0.012 $0.020 risen by 62.50%
$22 Positive interim results from US-veteran focused trial 8 Oct 2025 9:25AM $0.011 $0.020 risen by 77.27%
$22 Trading Halt 7 Oct 2025 8:57AM $0.011 $0.020 risen by 77.27%
$22 Change of Director's Interest Notice - John Mathias 2 Oct 2025 11:39AM $0.010 $0.020 risen by 95%
$22 Notification of cessation of securities - TRI 2 Oct 2025 11:38AM $0.010 $0.020 risen by 95%
$22 Appendix 4G 29 Sep 2025 11:10AM $0.011 $0.020 risen by 77.27%
$22 Corporate Governance Statement 29 Sep 2025 11:09AM $0.011 $0.020 risen by 77.27%
$22 2025 Annual Report 29 Sep 2025 11:09AM $0.011 $0.020 risen by 77.27%
$22 Notice of AGM and Closing Date for Director Nominations 25 Sep 2025 4:24PM $0.011 $0.020 risen by 77.27%
$22 Appendix 4E - Preliminary Final Report 29 Aug 2025 8:12AM $0.010 $0.020 risen by 95%
$22 Appendix 4E - Preliminary Final Report 29 Aug 2025 8:12AM $0.010 $0.020 risen by 95%
$22 30 patients enrolled in innovative mental health trial 25 Aug 2025 8:18AM $0.010 $0.020 risen by 95%
$22 June 2025 Quarterly Activities Report and Appendix 4C 31 Jul 2025 9:10AM $0.008 $0.020 risen by 143.75%
$22 Update on recruitment for mental health trial in veterans 17 Jul 2025 8:27AM $0.009 $0.020 risen by 129.41%
$22 First patient recruited in innovative mental health trial 19 Jun 2025 8:22AM $0.010 $0.020 risen by 95%
$22 Notification of cessation of securities - TRI 16 Jun 2025 4:48PM $0.009 $0.020 risen by 116.67%
$22 Cleansing Notice 11 Jun 2025 8:22AM $0.009 $0.020 risen by 116.67%
$22 Application for quotation of securities - TRI 11 Jun 2025 8:22AM $0.009 $0.020 risen by 116.67%
$22 Proposed issue of securities - TRI 10 Jun 2025 8:38AM $0.010 $0.020 risen by 95%
$22 Site activation for trial at West LA VA Medical Center 30 May 2025 8:23AM $0.010 $0.020 risen by 95%
$22 Notification regarding unquoted securities - TRI 20 May 2025 2:24PM $0.012 $0.020 risen by 62.50%
$22 Cleansing Notice 20 May 2025 9:46AM $0.012 $0.020 risen by 62.50%

51 - 75 of 206 results

Page 3 of 9

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.